Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCIDYS: Tocilizumab in Fibrous Dysplasia
NCT01791842Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2013
- Primary completion
- May 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in fibrous dysplasia of bone (FD), sponsored by Hospices Civils de Lyon. Started May 2013; status: completed.
02
Drugs
tocilizumab
03
Conditions
fibrous dysplasia of bone (FD)
Beyond the preview
Go deeper on NCT01791842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791842.